产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 药品制剂 CEFTRIAXONE SOD...

CEFTRIAXONE SODIUM FOR INJECTION

2024-12-24
南京市

产品详情

CEFTRIAXONE SODIUM FOR INJECTION
抗菌药与抗病毒药制剂
CEFTRIAXONE SODIUM FOR INJECTION,药品制剂,抗菌药与抗病毒药制剂
1vaii with 1 ampoule of sterile water
北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲

产品描述

 

Indications:

    For sensitive pathogenic bacteria due to lower respiratory tract infections, urinary tract, biliary tract infections, as well as intra-abdominal infections, pelvic infections, skin and soft tissue infections, bone and joint infections, septicemia, meningitis, and surgical infection prevention period. This product is simple single dose can cure gonorrhea.

Adverse reactions:

   Adverse reactions and treatment dose treatments. Local reaction phlebitis (1.86%), also may have skin rash, itching, fever, bronchial spasm, and serum sickness and other allergic reactions (2.77%), headache or dizziness (0.27%), diarrhea, nausea, vomiting, abdominal pain , colitis, jaundice, flatulence, taste disturbance and dyspepsia and other gastrointestinal reactions (3.45%). About 19% of laboratory abnormalities, which accounted for 14% of abnormal Blood tests, including an increase in eosinophils, platelets increase or decrease, and leukopenia. Liver and kidney dysfunction were 5% and 1.4% respectively.

Taboo:

  Allergy to cephalosporin antibiotics are banned.

江苏开元医药有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

江苏开元医药有限公司成立于2008年,总部位于江苏省南京市栖霞高新区-江苏生命科技园,现有员工500余人,全资子公司7家,是集生物医药研发、生产、贸易于一体的综合性生物医药国际化企业。主要产品覆盖医药中间体、原料药、成品药及医疗器械。从事仿制药一致性评价、改良新药和创新药开发、CRO和MAH等研发业务,拥有医药中间体、原料药、成品药等数个CDMO生产基地。公司年出口额超2亿美元,年销售额超15亿元,连续9年被中国医保商会授予“西成药出口十强企业”,连续6年跻身“中国医药国际化百强企业”。2017年公司成功当选为中国医药保健品进出口商会副会长单位。
业务类型:
成立日期:
年营业额:
主营产品类别: